Cormorant Asset Management, LP Q2 2021 Filing
Filed August 16, 2021
Portfolio Value
$2.9B
Holdings
103
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (103 positions)
| Stock | Value |
|---|---|
—TURNING POINT THERAPEUTICS I | $236.9M |
IWMISHARES TR | $229.4M |
AVIRATEA PHARMACEUTICALS INC | $137.7M |
—FORMA THERAPEUTICS HLDGS INC | $117.5M |
BBIOBRIDGEBIO PHARMA INC | $114.7M |
DSGNDESIGN THERAPEUTICS INC | $106.0M |
RVMDREVOLUTION MEDICINES INC | $106.0M |
OLMAOLEMA PHARMACEUTICALS INC | $86.0M |
BCABBIOATLA INC | $82.7M |
GLUEMONTE ROSA THERAPEUTICS INC | $69.5M |
ARKGARK ETF TR | $69.4M |
EWTXEDGEWISE THERAPEUTICS INC | $66.5M |
ARKKARK ETF TR | $65.4M |
RNAAVIDITY BIOSCIENCES INC | $55.1M |
APLSAPELLIS PHARMACEUTICALS INC | $53.7M |
ALXOALX ONCOLOGY HLDGS INC | $48.6M |
BMEABIOMEA FUSION INC | $48.4M |
—AMBRX BIOPHARMA INC | $47.0M |
—ZYMEWORKS INC | $45.9M |
AVTEAEROVATE THERAPEUTICS INC | $44.6M |
—PROMETHEUS BIOSCIENCES INC | $44.5M |
TARSTARSUS PHARMACEUTICALS INC | $43.9M |
STOKSTOKE THERAPEUTICS INC | $43.0M |
RCKTROCKET PHARMACEUTICALS INC | $42.9M |
VERVVERVE THERAPEUTICS INC | $40.6M |
—RAIN THERAPEUTICS INC | $39.7M |
ACRSACLARIS THERAPEUTICS INC | $35.1M |
OMEROMEROS CORP | $32.6M |
CNTACENTESSA PHARMACEUTICALS PLC | $31.1M |
MRTXEURMIRATI THERAPEUTICS INC | $28.3M |
YMABUSDY-MABS THERAPEUTICS INC | $27.0M |
AGENEURAGENUS INC | $26.4M |
—ELEVATION ONCOLOGY INC | $25.6M |
—VECTIVBIO HLDG AG | $25.5M |
TWSTTWIST BIOSCIENCE CORP | $24.7M |
RETAEURREATA PHARMACEUTICALS INC | $23.8M |
XLRNACCELERON PHARMA INC | $22.0M |
MASS908 DEVICES INC | $21.1M |
2L9BLUEPRINT MEDICINES CORP | $20.9M |
—LONGBOARD PHARMACEUTICALS IN | $20.9M |
1K0IGM BIOSCIENCES INC | $20.8M |
AXNX*AXONICS INC | $20.4M |
PRAXPRAXIS PRECISION MEDICINES I | $18.7M |
DMTKQDERMTECH INC | $18.7M |
ALGSALIGOS THERAPEUTICS INC | $18.5M |
—TALARIS THERAPEUTICS INC | $17.3M |
AKROAKERO THERAPEUTICS INC | $14.9M |
PLRXPLIANT THERAPEUTICS INC | $14.0M |
CABACABALETTA BIO INC | $13.9M |
PHVSPHARVARIS N V | $13.6M |
CCCCC4 THERAPEUTICS INC | $13.4M |
BEAMBEAM THERAPEUTICS INC | $12.9M |
CNTBCONNECT BIOPHARMA HLDGS LTD | $12.7M |
—APTOSE BIOSCIENCES INC | $12.6M |
GHRSGH RESEARCH PLC | $12.6M |
—MYOVANT SCIENCES LTD | $12.4M |
RPTXREPARE THERAPEUTICS INC | $11.3M |
ELDNELEDON PHARMACEUTICALS INC | $11.2M |
MORFMORPHIC HLDG INC | $10.9M |
0KB2HUMANIGEN INC | $10.4M |
ANABANAPTYSBIO INC | $10.0M |
ASNDASCENDIS PHARMA A/S | $9.9M |
ZLABZAI LAB LTD | $9.5M |
INSPINSPIRE MED SYS INC | $9.3M |
—BCTG ACQUISITION CORP | $9.1M |
GLTOUSDGALECTO INC | $8.9M |
—TCR2 THERAPEUTICS INC | $7.9M |
—HARPOON THERAPEUTICS INC | $7.5M |
—CATABASIS PHARMACEUTICALS IN | $7.5M |
5E7ITEOS THERAPEUTICS INC | $7.4M |
SPRYSILVERBACK THERAPEUTICS INC | $7.4M |
QUREUNIQURE NV | $7.4M |
IM8NINSMED INC | $7.1M |
VERUEURVERU INC | $6.5M |
VRDNVIRIDIAN THERAPEUTICS INC | $6.3M |
MRUSMERUS N V | $6.0M |
GRPHGRAPHITE BIO INC | $5.9M |
0HJQAVEO PHARMACEUTICALS INC | $5.9M |
DCPHEURDECIPHERA PHARMACEUTICALS IN | $5.3M |
—AKOUOS INC | $5.0M |
SRNESORRENTO THERAPEUTICS INC | $4.8M |
—MAGENTA THERAPEUTICS INC | $4.7M |
MLTXHELIX ACQUISITION CORP | $4.5M |
—QUOTIENT LTD | $4.4M |
TBPHTHERAVANCE BIOPHARMA INC | $4.4M |
DTILPRECISION BIOSCIENCES INC | $4.3M |
—5 01 ACQUISITION CORP | $4.0M |
—GENETRON HLDGS LTD | $2.7M |
AUTLAUTOLUS THERAPEUTICS PLC | $2.6M |
—HEALTH SCIENCES ACQ CORP 2 | $2.4M |
CLDNEUREIGER BIOPHARMACEUTICALS INC | $2.4M |
BCELATRECA INC | $2.3M |
1T7TRICIDA INC | $1.8M |
GOSSGOSSAMER BIO INC | $1.6M |
SWTXSPRINGWORKS THERAPEUTICS INC | $1.2M |
ORTXUSDORCHARD THERAPEUTICS PLC | $1.1M |
ASNSUSDX4 PHARMACEUTICALS INC | $676K |
CRDFCARDIFF ONCOLOGY INC | $637K |
NERVGBPMINERVA NEUROSCIENCES INC | $570K |
IMV1EURIMV INC | $507K |
Page 1 of 2Next